Literature DB >> 17563075

Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.

José-Tomás Navarro1, Evarist Feliu, Javier Grau, Blanca Espinet, Dolors Colomer, Josep-Maria Ribera, Albert Oriol, Isabel Granada, Jordi Juncà, Fuensanta Millá.   

Abstract

Chromosomal abnormalities in Ph-negative metaphases from patients with chronic myeloid leukemia (CML) treated with imatinib have been described in some cases. Trisomy 8 is the most frequent, but monosomy 7 has also been described. However, the association of these chromosomal alterations with myelodysplasia has been scarcely reported. We report the appearance of monosomy 7 in Ph-negative cells, associated with severe dysplasia, in two patients with CML treated with imatinib, with a different outcome: one with a transient evolution and the other evolving to acute myeloid leukemia. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563075     DOI: 10.1002/ajh.20859

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors.

Authors:  Monika Ribeiro de Mello Conchon; Israel Bendit; Patricia Ferreira; Walter Lima; Cristina Kumeda; Lucia Dias; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

2.  Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia: trisomy 10 may appear as an additional change.

Authors:  Moritaka Gotoh; Yuko Sasaki; Tomotaka Iguchi; Hiroaki Fujimoto; Atsushi Kodama; Hitoshi Kiyoi; Tomoki Naoe; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2008-06-20       Impact factor: 2.490

3.  Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

Authors:  Ghayas C Issa; Hagop M Kantarjian; Graciela Nogueras Gonzalez; Gautam Borthakur; Guilin Tang; William Wierda; Koji Sasaki; Nicholas J Short; Farhad Ravandi; Tapan Kadia; Keyur Patel; Raja Luthra; Alessandra Ferrajoli; Guillermo Garcia-Manero; Mary Beth Rios; Sara Dellasala; Elias Jabbour; Jorge E Cortes
Journal:  Blood       Date:  2017-08-23       Impact factor: 22.113

4.  Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.

Authors:  Arturo Vega-Ruiz; Susan O'Brien; Jorge Cortes; Partow Kebriaei; Deborah Thomas; Hagop Kantarjian; Farhad Ravandi
Journal:  Leuk Res       Date:  2008-03-19       Impact factor: 3.156

5.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

6.  Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells.

Authors:  M M da Rocha; L Otero; T F Padilha; J Dobbin; C de Souza Fernandez; E Abdelhay; T de Souza Fernandez
Journal:  Blood Cancer J       Date:  2011-11-11       Impact factor: 11.037

7.  Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.

Authors:  Majd D Jawad; Ronald S Go; Rhett P Ketterling; Kebede H Begna; Kaaren K Reichard; Min Shi
Journal:  Clin Case Rep       Date:  2016-02-08

8.  TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.

Authors:  Peter Valent; Susanne Herndlhofer; Mathias Schneeweiß; Bernd Boidol; Anna Ringler; Stefan Kubicek; Karoline V Gleixner; Gregor Hoermann; Emir Hadzijusufovic; Leonhard Müllauer; Wolfgang R Sperr; Giulio Superti-Furga; Christine Mannhalter
Journal:  Oncotarget       Date:  2017-04-04

Review 9.  Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.

Authors:  Fabian Lang; Lydia Wunderle; Heike Pfeifer; Susanne Schnittger; Gesine Bug; Oliver G Ottmann
Journal:  Am J Case Rep       Date:  2017-10-16

10.  Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.

Authors:  Peter Valent
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.